1Department of Pathogen Biology & Microbiology, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058 China.
2Department of General Intensive Care Unit of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058 China.
Commun Biol. 2019 Jan 25;2:36. doi: 10.1038/s42003-018-0278-1. eCollection 2019.
Colistin is the last-resort antibiotic against lethal infections with multidrug-resistant bacterial pathogens. A rainbow coalition of mobile colistin resistance () genes raises global health concerns. Here, we describe the action and mechanism of colistin resistance imparted by MCR-4, a recently-identified member from the broader MCR family. We found that MCR-4 originates from the silenced variant of via progressive evolution and forms a phylogenetically-distinct group from the well-studied MCR-1/2 family. Domain-swapping experiments further confirmed that MCR-1 and MCR-4 transmembrane and catalytic domains are not functionally-interchangeable. However, structural and functional analyses demonstrated that MCR-4 possesses a similar PE lipid substrate-recognizable cavity and exploits an almost-identical ping-pong catalysis mechanism. MCR-4 also can alleviate colistin-triggered accumulation of reactive oxygen species (ROS). Taken together, this finding constitutes a functional proof that MCR-4 proceeds in a distinct evolutionary path to fulfill a consistent molecular mechanism, resulting in phenotypic colistin resistance.
黏菌素是治疗多重耐药细菌病原体引起的致命感染的最后手段抗生素。由移动黏菌素耐药基因组成的彩虹联盟引起了全球健康关注。在这里,我们描述了最近从更广泛的 MCR 家族中鉴定出的成员 MCR-4 赋予黏菌素耐药的作用和机制。我们发现 MCR-4 源自沉默的变体,通过渐进进化形成一个与经过充分研究的 MCR-1/2 家族在系统发育上明显不同的群体。结构域交换实验进一步证实,MCR-1 和 MCR-4 的跨膜和催化结构域在功能上不能互换。然而,结构和功能分析表明,MCR-4 具有相似的 PE 脂质底物识别腔,并利用几乎相同的乒乓催化机制。MCR-4 还可以减轻黏菌素引发的活性氧(ROS)积累。总之,这一发现构成了一个功能证明,即 MCR-4 沿着一条独特的进化途径前进,以实现一致的分子机制,从而导致表型黏菌素耐药。